Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

IDO-1 inhibitor LY3381916 × Classical hematology × 30 days × Clear all

Sponsor

Interventions

fludarabine 5 Mycophenolic Acid 5 Cyclophosphamide 5 fludarabine phosphate 4 Tacrolimus 4 Biopsy 4 Whole-Body Irradiation 3 Specimen Handling 3 Azacitidine 3 venetoclax 2 thymoglobulin 2 apixaban 2 Vorinostat 2 Peripheral Blood Stem Cell Transplantation 2 Lenalidomide 2 Bone Marrow Transplantation 2 treosulfan 1 poly ICLC 1 edoxaban 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 abelacimab 1 X-Rays 1 TAK-243 1 Surgical Procedures, Operative 1 Stem Cell Transplantation 1 Spectrometry, Fluorescence 1 Sirolimus 1 S-Adenosylmethionine 1 Rivaroxaban 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡